In-vitro aerodynamic particle size distribution of the Symbicort® Turbuhaler® at different inhalation flows using an anderson cascade impactor

被引：0
|
作者：
Almeziny, M. [1 ]
Clark, B. [1 ]
机构：
[1] Univ Bradford, Sch Pharm, Bradford BD7 1DP, W Yorkshire, England
来源：
JOURNAL OF PHARMACY AND PHARMACOLOGY | 2010年 / 62卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1280 / 1281
页数：2
相关论文
共 11 条
  • [1] Comparison of Aerodynamic Particle Size Distribution Between a Next Generation Impactor and a Cascade Impactor at a Range of Flow Rates
    Yoshida, Hiroyuki
    Kuwana, Akemi
    Shibata, Hiroko
    Izutsu, Ken-ichi
    Goda, Yukihiro
    AAPS PHARMSCITECH, 2017, 18 (03): : 646 - 653
  • [2] Comparison of Aerodynamic Particle Size Distribution Between a Next Generation Impactor and a Cascade Impactor at a Range of Flow Rates
    Hiroyuki Yoshida
    Akemi Kuwana
    Hiroko Shibata
    Ken-ichi Izutsu
    Yukihiro Goda
    AAPS PharmSciTech, 2017, 18 : 646 - 653
  • [3] Aerodynamic characteristics of a dry powder inhaler at low inhalation flows using a mixing inlet with an Andersen Cascade Impactor
    Nadarassan, Dinesh Kumar
    Assi, Khaled H.
    Chrystyn, Henry
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 39 (05) : 348 - 354
  • [4] Measurement of Aerodynamic Particle Size Distribution of Orally Inhaled Products by Cascade Impactor: How to Let the Product Specification Drive the Quality Requirements of the Cascade Impactor
    Roberts, Daryl L.
    Mitchell, Jolyon P.
    AAPS PHARMSCITECH, 2019, 20 (02)
  • [5] Measurement of Aerodynamic Particle Size Distribution of Orally Inhaled Products by Cascade Impactor: How to Let the Product Specification Drive the Quality Requirements of the Cascade Impactor
    Daryl L. Roberts
    Jolyon P. Mitchell
    AAPS PharmSciTech, 20
  • [6] INVESTIGATION INTO THE IN VITRO PERFORMANCE OF ANTI-STATIC VHCS BY PARTICLE SIZE DISTRIBUTION USING THE NEXT GENERATION PHARMACEUTICAL IMPACTOR (NGI)
    Courtney, Scott
    Pratt, Benjamin
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2016, 29 (03) : A24 - A24
  • [7] Relative Precision of Inhaler Aerodynamic Particle Size Distribution (APSD) Metrics by Full Resolution and Abbreviated Andersen Cascade Impactors (ACIs): Part 2—Investigation of Bias in Extra-Fine Mass Fraction with AIM-HRT Impactor
    Jolyon P. Mitchell
    Mark W. Nagel
    Cathy C. Doyle
    Rubina S. Ali
    Valentina I. Avvakoumova
    J. David Christopher
    Jorge Quiroz
    Helen Strickland
    Terrence Tougas
    Svetlana Lyapustina
    AAPS PharmSciTech, 2010, 11 : 1115 - 1118
  • [8] Relative Precision of Inhaler Aerodynamic Particle Size Distribution (APSD) Metrics by Full Resolution and Abbreviated Andersen Cascade Impactors (ACIs): Part 2-Investigation of Bias in Extra-Fine Mass Fraction with AIM-HRT Impactor
    Mitchell, Jolyon P.
    Nagel, Mark W.
    Doyle, Cathy C.
    Ali, Rubina S.
    Avvakoumova, Valentina I.
    Christopher, J. David
    Quiroz, Jorge
    Strickland, Helen
    Tougas, Terrence
    Lyapustina, Svetlana
    AAPS PHARMSCITECH, 2010, 11 (03): : 1115 - 1118
  • [9] Determination of Passive Dry Powder Inhaler Aerodynamic Particle Size Distribution by Multi-Stage Cascade Impactor: International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) Recommendations to Support Both Product Quality Control and Clinical Programs
    Mitchell, Jolyon P.
    Stein, Stephen W.
    Doub, William
    Goodey, Adrian P.
    Christopher, J. David
    Patel, Rajni B.
    Tougas, Terrence P.
    Lyapustina, Svetlana
    AAPS PHARMSCITECH, 2019, 20 (05)
  • [10] Determination of Passive Dry Powder Inhaler Aerodynamic Particle Size Distribution by Multi-Stage Cascade Impactor: International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) Recommendations to Support Both Product Quality Control and Clinical Programs
    Jolyon P. Mitchell
    Stephen W. Stein
    William Doub
    Adrian P. Goodey
    J. David Christopher
    Rajni B. Patel
    Terrence P. Tougas
    Svetlana Lyapustina
    AAPS PharmSciTech, 20
12